Gianna Melillo on Muck Rack

Gianna Melillo

Verified
Philadelphia
As seen in: American College of Physicians, Yahoo News, Aol, Changing America, The Hill, Yahoo Sports, Miami Herald, Yahoo, The Charlotte Observer, KTLA-TV (Los Angeles, CA), The Sacramento Bee and
Senior Writer @ACPIMPhysicians Formerly @ChangingAmerica @thehill @ajmc_journal Bylines in @Drug_Topics @MHExecutive

Get in touch with Gianna

Contact Gianna, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Figuring out family planning

|
By Gianna Melillo Verified, ACP Internist
Starting a family can be daunting for any young professional. For early career physicians, though, the unique demands of the job can make this chapter in life particularly challenging. Long hours, potential hazardous workplace exposures, and stigma against motherhood are just a few of the hurdles newly employed physicians encounter. Add to that the emotional, physical, and financial toll of childbearing, and many decide to put it off.
Open in Who Shared Issue with article?

FDA approves second generic form of mifepristone

|
By Gianna Melillo Verified, ACP Internist
Recalls and warnings A notification from Boston Scientific that certain Endotak Reliance defibrillation leads with expanded polytetrafluoroethylene-coated coils may incur calcification that impacts shock efficacy and/or requires early replacement. A total of 386 serious injuries and 16 patient deaths have been reported to be associated with this issue. A class I recall of certain ViziShot 2 FLEX (19G) products by Olympus due to a potentially deformed atraumatic tip.
Open in Who Shared Issue with article?

RSV vaccine effective in the real world, manufacturer study finds

|
By Gianna Melillo Verified, Janet Colwell, ACP Internist
https://immattersacp.org/weekly/archives/2025/10/28/2.htm I.M. Matters Weekly | Vaccination | October 28, 2025 The respiratory syncytial virus (RSV) vaccine was 92% effective against hospitalization or ED visits due to RSV in an analysis of adults ages 60 years or older vaccinated during the 2023-2024 season. A respiratory syncytial virus (RSV) vaccine showed effectiveness against acute respiratory illness, including severe disease, an industry-funded study found.
Open in Who Shared Issue with article?
See all 1,194 licensed articles (2,165 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified